These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. Schmidt D; Dijkman PE; Driessen-Mol A; Stenger R; Mariani C; Puolakka A; Rissanen M; Deichmann T; Odermatt B; Weber B; Emmert MY; Zund G; Baaijens FP; Hoerstrup SP J Am Coll Cardiol; 2010 Aug; 56(6):510-20. PubMed ID: 20670763 [TBL] [Abstract][Full Text] [Related]
8. Human or animal homograft: could they have a future as a biological scaffold for engineered heart valves? Dainese L; Biglioli P J Cardiovasc Surg (Torino); 2010 Jun; 51(3):449-56. PubMed ID: 20523298 [TBL] [Abstract][Full Text] [Related]
10. Current Status of Tissue Engineering Heart Valve. Shinoka T; Miyachi H World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):677-684. PubMed ID: 27834758 [TBL] [Abstract][Full Text] [Related]
11. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156 [TBL] [Abstract][Full Text] [Related]
12. Biofabrication of a three-dimensional liver micro-organ as an in vitro drug metabolism model. Chang R; Emami K; Wu H; Sun W Biofabrication; 2010 Dec; 2(4):045004. PubMed ID: 21079286 [TBL] [Abstract][Full Text] [Related]